Detalhe da pesquisa
1.
Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studies.
Mov Disord
; 31(7): 1054-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27214258
2.
Serum neurofilament light as a biomarker in progressive multiple sclerosis.
Neurology
; 95(10): 436-444, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675076
3.
Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
Eur Neurol
; 60(4): 186-99, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18667827
4.
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.
Sci Rep
; 8(1): 16970, 2018 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30451888
5.
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Nat Rev Drug Discov
; 17(4): 280-299, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217836
6.
Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study.
J Neurodev Disord
; 8: 1, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26855682
7.
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Sci Transl Med
; 8(321): 321ra5, 2016 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26764156
8.
Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Clin Neurophysiol
; 115(11): 2530-41, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15465443
9.
Development of mavoglurant and its potential for the treatment of fragile X syndrome.
Expert Opin Investig Drugs
; 23(1): 125-34, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251408
10.
The challenges of clinical trials in fragile X syndrome.
Psychopharmacology (Berl)
; 231(6): 1237-50, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173622